Skeletal muscle abnormalities in patients with COPD: Contribution to exercise intolerance

Medicine and Science in Sports and Exercise

Volumn 30, Issue 7, 1998, Pages 1019-1027

  Serres, Isabelle ^a   Hayot, Maurice ^b   Préfaut, Christian ^b   Mercier, Jacques ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NONE

Author keywords

COPD; Exercise; Skeletal muscle; Training

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; THEOPHYLLINE;

ARTICLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; ENZYME ACTIVITY; EXERCISE TOLERANCE; HUMAN; HYPOXEMIA; MUSCLE METABOLISM; MYOPATHY; NUTRITIONAL STATUS; SKELETAL MUSCLE; TRAINING;

ENERGY METABOLISM; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUSCLE, SKELETAL; NUTRITION DISORDERS; RESPIRATORY MECHANICS;

EID: 0031847221     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199807000-00001     Document Type: Article

References (93)

1. AGUAR, M. C., J. GEA, M. PASTO, J. A. COROMINAS, J. MINGUELLA, and J. M. BROQUETAS. Structure of the external intercostal muscle and inspiratory muscle function during exercise in COPD patients (Abstract). Am. J. Respir. Crit. Care Med. 153(Suppl.):A22, 1996.
2. ARORA, N. S. and D. F. ROCHESTER. Effect of chronic airflow limitation (CAL) on sternomastoid muscle thickness. Chest 85: 585-595, 1984.
3. ARORA, N. S. and D. F. ROCHESTER. COPD and human diaphragm muscle dimensions. Chest 91:719-724, 1987.
4. BELMAN, M. J. and B. A. KENDREGAN. Exercise training fails to increase skeletal muscle enzymes in patients with COPD. Am. Rev. Respir. Dis. 123:256-261, 1981.
5. BROOKS, G. A. and J. MERCIER. The balance of carbohydrate and lipid utilization during exercise: the 34 crossover 34 concept. J. Appl. Physiol. 76:2253-2261, 1994.
6. BROWN, S. E., S. WIENER, R. A. BROWN, P. A. MARCARELLI, and R. W. LIGHT. Exercise performance following a carbohydrate load in chronic airflow limitation. J. Appl. Physiol. 58:1340-1346, 1985.
7. BUTLER, C. Diaphragmatic changes in emphysema. Am. Rev. Respir. Dis. 114:155-159, 1976.
8. CAMPBELL, J. A., R. L. HUGHES, V. SAHGAL, J. FREDERIKSEN, and T. W. SHIELDS. Alterations in intercostal muscle morphology and biochemistry in patients with obstructive lung disease. Am. Rev. Respir. Dis. 122:679-686, 1980.
9. CASABURI, R., A. PATESSIO, F. LOLI, S. ZANABONI, C. F. DONNER, and K. WASSERMAN. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am. Rev. Respir. Dis. 143:9-18, 1991.
10. CLARK, C. J., L. COCHRANE, and E. MACKAY. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur. Respir. J. 9:2590-2596, 1996.
11. COYLE, E. F., W. H. MARTIN III, D. R. SINACORE, M. J. JOYNER, J. M. HAGBERG, and J. O. HOLLOSZY. Time course of loss of adaptations after stopping prolonged intense endurance training. J. Appl. Physiol. 57:1857-1864, 1984.
12. DE TROYER, A. Effect of hyperinflation on the diaphragm. Eur. Respir. J. 10:708-713, 1997.
13. DECRAMER, M., V. DE BOCK, and R. DOM. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153:1958-1964, 1996.
14. DEKHUIJZEN, P. N., G. GAYAN-RAMIREZ, and M. DECRAMER. Does corticosteroid treatment affect the respiratory muscles. Eur. Respir. J. 6:465-466, 1993.
15. DILLARD, T. A., S. PIANTADOSI, and K. R. RAJAGOPAL. Prediction of ventilation at maximal exercise in chronic air-flow obstruction. Am. Rev. Respir. Dis. 132:230-235, 1985.
16. DILLARD, T. A., S. PIANTADOSI, and K. R. RAJAGOPAL. Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest 96:267-271, 1989.
17. DODD, S. L., S. K. POWERS, I. S. VRABAS, D. CRISWELL, S. STETSON, and R. HUSSAIN. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle. Med. Sci. Sports Exerc. 28:669-676, 1996.
18. DRIVER, A. G., M. T. MACALEVY, and J. L. SMITH. Nutritional aspects of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest 82:568-571, 1982.
19. EFTHIMIOU, J., J. FLEMING, C. GOMES, and S. G. SPIRO. The effects of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 137:1075-1082, 1988.
20. ENGELEN, M. P., A. M. SCHOLS, W. K. BAKEN, G. J. WESSELING, and E. F. WOUTERS. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD. Eur. Respir. J. 7:1793-1797, 1994.
21. FARKAS, G. A. and C. ROUSSOS. Diaphragm in emphysematous hamsters: sarcomere and adaptability. J. Appl. Physiol. 53:1263-1272, 1982.
22. FIACCADORI, E., S. DEL CANALE, P. VITALI, E. COFFRINI, N. RONDA, and A. GUARIGLIA. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest 5:883-887, 1992.
23. FRANKFORT, J. D., C. E. FISCHER, D. W. STANSBURY, D. L. MACARTHUR, S. E. BROWN, and R. W. LIGHT. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest 100:792-795, 1991.
24. GAYAN-RAMIREZ, G. and M. DECRAMER. Inotropic effects of theophylline on foreshortened canine diaphragm. Am. J. Respir. Crit. Care Med. 149:920-924, 1994.
25. GERTZ, I., G. HEDENSTIERNA, G. HELLERS, and J. WAHREN. Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. Clin. Sci. Mol. Med. 52:395-403, 1977.
26. GOLLNICK, P. D. and B. SALTIN. Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin. Physiol. 2:1-12, 1982.
27. GOSSELINK, R. and M. DECRAMER. Inspiratory muscle training: Where are we? Eur. Respir. J. 7:2103-2105, 1994.
28. GOSSELINK, R., T. TROOSTERS, and M. DECRAMER. Peripheral muscle weakness contributes to exercise limitation in COPD. Am. J. Respir. Crit. Care Med. 153:976-980, 1996.
29. HAMILTON, A. L., K. J. KILLIAN, E. SUMMERS, and N. L. JONES. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am. J. Respir. Crit. Care Med. 152:2021-2031, 1995.
30. HAYOT, M., P. MESSNER-PELLENC, M. RAMONATXO, et al. Relationship between inspiratory muscle function and maximal exercise in patients with chronic obstructive lung disease and patients with chronic heart failure. Am. J. Respir. Crit. Care Med. 155(Suppl.): A912, 1997.
31. HEJDRA, Y. F., P. N. DEKHUIJZEN, C. L. HERWAARDEN, et al. Effects of body position, hyperinflation, and blood gas tensions on maximal respiratory pressures in patients with chronic obstructive pulmonary disease. Thorax 49:453-458, 1994.
32. HOLLOSZY, J. O. Adaptation of skeletal muscle to endurance exercise. Med. Sci. Sports Exerc. 7:155-164, 1975.
33. HUGHES, R. L., H. KATZ, V. SAHGAL, J. A. CAMPBELL, R. HARTZ, and T. W. SHIELDS. Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung disease. Respiration 44:321-328, 1983.
34. ISHIKAWA, S. and J. A. HAYES. Functional morphometry of the diaphragm in patients with chronic obstructive lung disease. Am. Rev. Respir. Dis. 108:135-138, 1973.
35. JAKOBSSON, P, L. JORFELDT, and A. BRUNDIN. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur. Respir. J. 3:192-196, 1990.
36. JAKOBSSON, P., L. JORFELDT, and J. HENRIKSSON. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 151:374-377, 1995.
37. JAKOBSSON, P. and L. JORFELDT. Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxemia. Respir. Med. 89:471-476, 1995.
38. KELSEN, S. G., T. WOLANSKI, G. S. SUPINSKI, and U. ROESSMANN. The effect of elastase-induced emphysema on diaphragmatic muscle structure in hamsters. Am. Rev. Respir. Dis. 127:330-334, 1983.
39. KILLIAN, K. J., P. LEBLANC, D. H. MARTIN, E. SUMMERS, N. L. JONES, and E. J. M. CAMPBELL. Exercise capacity and ventilatory, circulatory and symptom limitation in patient with chronic airflow limitation. Am. Rev. Respir. Dis. 146:935-940, 1992.
40. KIRKWOOD, S. P., L. PACKER, and G. A. BROOKS. Effects of endurance training on a mitochondrial reticulum in limb skeletal muscle. Arch. Biochem. Biophys. 255:80-88, 1987.
41. KONGRAGUNTA, V. R., W. S. DRUZ, and J. T. SHARP. Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease: responses to theophylline. Am. Rev. Respir. Dis. 13:662-667, 1988.
42. KUTSUZAWA, T., S. SHIOYA, D. KURITA, M. HAIDA, Y. OHTA, and H. YAMABAYASHI. P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am. Rev. Respir. Dis. 146:1019-1024, 1992.
43. KUTSUZAWA, T., S. SHIOYA, D. KURITA, M. HAIDA, Y. OHTA, and H. YAMABAYASHI. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:647-652, 1995.
44. LEVINE, S., L. KAISER, J. LEFEROVITCH, T. NGUYEN, and B. A. TIKUNOV. Myosin heavy chain composition and fiber type distribution in the lateral costal diaphragm of normal subjects and patients with chronic obstructive pulmonary disease (Abstract). Am. J. Respir. Crit. Care Med. 155(Suppl.):A510, 1997.
45. LISBOA, C., V. MUNOZ, T. BEROIZA, A. LEIVA, and E. CRUZ. Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold breathing device. Eur. Respir. J. 7:1266-1274, 1994.
46. LOISEAU, A., C. DUBREUIL, P. LOISEAU, J. C. PUJET, R. GEORGES, and G. SAUMON. Exercise tolerance in chronic obstructive pulmonary disease: importance of active and passive components of the ventilatory system. Eur. Respir. J. 2:522-527, 1989.
47. MACDOUGALL, J. D., G. R. WARD, D. G. SALE, and J. R. SUTTON. Biochemical adaptation of human skeletal muscle to heavy resistance training and immobilization. J. Appl. Physiol. 43:700-703, 1977.
48. MACEVOY, C. E. and D. E. NIEWOEHNER. Adverse effects of corticosteroid therapy for COPD. Chest 111:732-743, 1997.
49. MACRAE, H. S., T. D. NOAKES, and S. C. DENNIS. Role of decreased carbohydrate oxidation on slower rises in ventilation with increasing exercise intensity after training. Eur. J. Appl. Physiol. 71:523-529, 1995.
50. MALTAIS, F., A. A. SIMARD, C. SIMARD, J. JOBIN, P. DESGAGNES, and P. LEBLANC. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am. J. Respir. Crit. Care Med. 153:288-293, 1996.
51. MALTAIS, F., P. LEBLANC, C. SIMARD, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154:442-447, 1996.
52. MANNIX, E. T., M. D. BOSKA, P. GALASETTI, G. BURTON, F. MANFREDI, and M. O. FARBER. Modulation of ATP production by oxygen in obstructive lung disease as assessed by. 31P-MRS. J. Appl. Physiol. 78:2218-2227, 1995.
53. MARSH, G. D., R. G. MACFADDEN, R. L. NICHOLSON, D. J. LEASA, and R. T. THOMPSON. Theophylline delays skeletal muscle fatigue during progressive exercise. Am. Rev. Respir. Dis. 147:876-879, 1993.
54. MOXHAM, J., J. MILLER, C. M. WILES, A. MORRIS, and M. GREEN. Effect of aminophylline on the human diaphragm. Thorax 40: 288-292, 1985.
55. MURCIANO, D., M. AUBIER, Y. LECOCGUIC, and R. PARIENTE. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N. Engl. J. Med. 311:349-353, 1984.
56. NAVA, S., G. GAYAN-RAMIREZ, H. ROLLIER, A. BISSCHOP, R. DOM, V. DE BOCK, and M. DECRAMER. Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am. J. Respir. Crit. Care Med. 153:1888-1896, 1996.
57. OLIVEN, A., G. S. SUPINSKI, and S. G. KELSEN. Functional adaptation of diaphragm to chronic hyperinflation in emphysematous hamsters. J. Appl. Physiol. 60:225-231, 1986.
58. OROZCO-LEVI, M., J. GEA, M. C. AGUAR, J. M. MARTIN-CAMPOS, M. FELEZ, and J. M. BROQUETAS. Expression of myosin heavy chain isoforms in external intercostals of COPD patients (Abstract). Am. J. Respir. Crit. Care Med. 155(Suppl.):A510, 1997.
59. PALANGE, P., S. FORTE, A. FELLI, P. GALASETTI, P. SERRA, and S. CARLONE. Nutritional state and exercise tolerance in patients with COPD. Chest 107:1206-1212, 1995.
60. PAYEN, J. F., B. WUYAM, P. LEVY, ET AL. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am. Rev. Respir. Dis. 147:592-598, 1993.
61. PECHE, R., M. ESTENNE, P. A. GEVENOIS, E. BRASSINE, J. C. YERNAULT, and A. DE TROYER. Sternomastoid muscle size and strength in patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153:422-425, 1996.
62. POOLE, D. C., W. L. SEXTON, G. A. FARKAS, S. K. POWERS, and M. REID. Diaphragm structure and function in health and disease. Med. Sci. Sports Exerc. 6:738:754, 1997.
63. PRÉFAUT, C., A. VARRAY, and G. VALLET. Pathophysiological basis of exercise training in patients with chronic obstructive lung disease. Eur. Respir. Rev. 5:27-32, 1995.
64. RAMONATXO, M., P. BOULARD, and C. PRÉFAUT. Validation of a noninvasive tension-time index of inspiratory muscles. J. Appl. Physiol. 78:646-653, 1995.
65. ROCHESTER, D. F. and N. M. BRAUN. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 132:42-47, 1985.
66. ROCHESTER, D. Respiratory muscles: structure, size, and adaptative capacity In: Breathlessness: The Campbell Symposium, N. L. Jones, K. J. Killian (Eds.). Hamilton, Ontario: Boehringer Ingelheim, 1992, pp. 2-12.
67. SANCHEZ, J., J. P. DERENNE, B. DEBESSE, M. RIQUET, and H. MONOD. Typology of the respiratory muscles in normal men and in patients with moderate chronic respiratory diseases. Bull. Eur. Physiopath. Respir. 18:901-914, 1982.
68. SANCHEZ, J., C. BASTIEN, G. MEDRANO, M. RIQUET, and J. DERENNE. Metabolic enzymatic activities in the diaphragm of normal men and patients with moderate chronic obstructive pulmonary disease. Bull. Eur. Physiopath. Respir. 20:535-540, 1984.
69. SANCHEZ, J., G. MEDRANO, B. DEBESSE, M. RIQUET, and J. DERENNE. Muscle fibre types in costal and crural diaphragm in normal men and in patients with moderate chronic respiratory disease. Bull. Eur. Physiopath. Respir. 21:351-356, 1985.
70. SANCHEZ, J., A. BRUNET, G. MEDRANO, B. DEBESSE, and J. DERENNE. Metabolic enzyme activities in the intercostal and serratus muscles and in the latissimus dorsi of middle-aged normal men and patients with moderate obstructive pulmonary disease. Eur. Respir. J. 1:376-383, 1988.
71. SAUNIER, C., M. GIMENEZ, and D. HARTEMANN. Métabolisme glycolitique du sang pendant l'exercice musculaire dans les bronchopneumopathies chroniques hypoxémiques. Bull. Eur. Physiopath. Respir. 15:291-302, 1979.
72. SCHOLS, A. M., P. B. SOETERS, R. MOSTERT, W. H. SARIS, and E. F. WOUTERS. Energy balance in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1248-1252, 1991.
73. SCHOLS, A. M., R. MOSTERT, P. B. SOETERS, and E. F. WOUTERS. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 46:695-699, 1991.
74. SERRES, I., A. VARRAY, G. VALLET, J. P. MICALLEF, and C. PRÉFAUT. Improved skeletal muscle performance after individualized exercise training in patients with COPD. J. Cardiopulm. Rehabil. 17:232-238, 1997.
75. SERRES, I., V. GAUTIER, A. VARRAY, and C. PRÉFAUT. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 113:900-905, 1998.
76. SHARP, J. T., G. A. BEARD, M. SUNGA, et al. The rib cage in normal and emphysematous subjects: a roentgenographic approach. J. Appl. Physiol. 61:2050-2059, 1986.
77. SIMILOWSKI, T. and J. P. DERENNE. Inspiratory muscle testing in stable COPD patients. Eur. Respir. J. 7:1871-1876, 1994.
78. SMITH, K., D. COOK, G. H. GUYATT, J. MADHAVAN, and A. D. OXMAN. Respiratory muscle training in chronic airflow limitation: a meta-analysis. Am. Rev. Respir. Dis. 145:533-539, 1992.
79. STEEL, R. H., and B. E. HEARD. Size of the diaphragm in chronic bronchitis. Thorax 28:55-60, 1973.
80. SUE, Y. D., K. WASSERMAN, R. B. MORICCA, and R. CASABURI. Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease: use of the V. slope method for anaerobic threshold determination. Chest 94:931-938, 1988.
81. SUPINSKI, G. S., and S. G. KELSEN. Effect of elastase-induced emphysema on the force generating ability of the diaphragm. J. Clin. Invest. 70:978-988, 1982.
82. TADA, H., H. KATO, T. MISAWA, et al. P-Nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur. Respir. J. 5:163-169, 1992.
83. THURLBECK, W. M. Diaphragm and body weight in emphysema. Thorax 33:483-487, 1978.
84. TOBIN, M. J. Respiratory muscles in disease. Clin. Chest. Med. 9:263-286, 1988.
85. VALLET, G., S. AHMAIDI, I. SERRES, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur. Respir. J. 10:114-122, 1997.
86. WANKE, T., D. FORMANEK, H. LAHRMANN, et al. Effects of combined inspiratory muscle and cycle ergometer training on exercise performance in patients with COPD. Eur. Respir. J. 7:2205-2211, 1994.
87. WANKE, T., M. MERCKLE, U. ZIFKO, et al. The effects of aminophylline on the force-length characteristics of the diaphragm. Am. J. Respir. Crit. Care Med. 149:1545-1549, 1994.
88. WHITTAKER, J. S., C. F. RYAN, P. A. BUCKLEY, and J. D. ROAD. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am. Rev. Respir. Dis. 142:283-288, 1990.
89. WIJKSTRA, P. J., E. M. TENVERGERT, T. W. VAN DER MARK, et al. Relation of lung function, maximal inspiratory pressure, dyspnea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 49:468-472, 1994.
90. WILSON, O. D., R. M. ROGERS, E. C. WRIGHT, and N. R. ANTHONISEN. Body weight in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 139:1435-1438, 1989.
91. WUYAM, B., J. F. PAYEN, P. LEVY, et al. Metabolism and aerobic capacity in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur. Respir. J. 5:157-162, 1992.
92. YOUNG, A. Rehabilitation of patients with pulmonary disease. Ann. Acad. Med. 12:410-416, 1983.
93. ZATTARA-HARTMAN, M. C., M. BADIER, C. GUILLOT, C. TOMEI, and Y. JAMMES. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 18:495-502, 1995.